Physician profile
Maria B Wright
NPI 1962491126
$1,429.74
in general payments reported to CMS, 2019-2025
20 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.17 · 2020: $61.02 · 2021: $276 · 2022: $264 · 2023: $279 · 2024: $271 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $441.66 | 2022-2025 | Veozah |
| Abbvie INC. | $338.80 | 2021-2025 | |
| Novo Nordisk INC | $114.31 | 2020-2023 | Wegovy |
| Mayne Pharma Commercial LLC | $101.37 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $68.64 | 2019-2022 | |
| Glaxosmithkline, LLC. | $53.10 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Corcept Therapeutics | $44.12 | 2024 | Korlym |
| Allergan, INC. | $41.31 | 2019-2020 | |
| Eisai INC. | $32.44 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.86 | 2019-2022 | |
| Medtronic, INC. | $22.20 | 2022 | |
| Edwards Lifesciences Corporation | $20.72 | 2019 | |
| Exact Sciences Corporation | $20.69 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $20.28 | 2019 | |
| Endo Pharmaceuticals INC. | $20.18 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $15.60 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.15 | 2021 | |
| Amgen INC. | $13.34 | 2022 | |
| Qol Medical, LLC | $13.15 | 2023 | Sucraid |
| Phathom Pharmaceuticals, INC. | $7.82 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.